Practice-changing melanoma and skin cancer treatments come from clinical trials.
Melanoma and Skin Cancer Trials (MASC Trials) is Australia and New Zealand’s collaborative trials group specialising in investigator-initiated melanoma and skin cancer research. Working with leading researchers and institutions locally and around the globe, MASC Trials develops, conducts, and publishes research and clinical trials that improve how we diagnose and treat melanoma and skin cancer.
What We Do
MASC Trials brings together a powerful network of almost 2,000 professionals who represent the many disciplines critical to our work – oncologists, surgeons, radiation specialists, nurses, allied health professionals, health economists, statisticians, research scientists, clinical research associates, data managers, patient advocates and others.
With expert support from our Advisories and our trials staff, MASC Trials leads and designs research and clinical trial development, and provides project management for multicentre, national and international collaborations.
Active trials closed for recruitment
Active trials in start up
Professor H. Peter Soyer is focused on improving the early detection of skin cancer through a nationwide melanoma screening program.